Bristol Myers Squibb Q1 2025 Financial Summary

Bristol Myers Squibb reported first quarter 2025 revenues of $11.2 billion, down 6% year-over-year (4% decline excluding foreign exchange). Growth Portfolio revenues rose 16% to $5.6 billion (18% excluding FX).

GAAP earnings per share were $1.20; non-GAAP EPS came in at $1.80.

The company raised its full-year 2025 outlook:
- Revenue guidance is now ~$45.8 billion to $46.8 billion
- Non-GAAP EPS guidance is increased to $6.70 to $7.00

Management attributed the results to strong momentum in its Growth Portfolio and disciplined execution.